Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
| Autor: | Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW, COMPLY (COMPlement inhibition in myocardial infarction treated with thromboLYtics) Investigators, Mahaffey, Kenneth W, Granger, Christopher B, Nicolau, Jose C, Ruzyllo, Witold, Weaver, W Douglas, Theroux, Pierre, Hochman, Judith S, Filloon, Thomas G |
|---|---|
| Zdroj: | Circulation; 2003 Sep 9, Vol. 108 Issue 10, p1176-1183, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|